Back to first-pass browser

First-pass extracted concept

VTA GABA neurons

Candidate: concept label1 source documents4 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Aliases

ventral tegmental area GABA neurons

Extracted Explainers

What the tool is doing

VTA GABA neurons are described as inhibitory neurons in the ventral tegmental area that both locally inhibit dopamine neurons and project inhibitory signals to distal brain regions. The review frames them as active contributors to reward and aversion rather than only local interneurons.

Source 1DOIPubMed

What problem it solves

As a concept, this cell population helps explain how inhibitory signaling in the VTA can shape motivation, reward, aversion, and stress-linked behaviors.

Source 1DOIPubMed

What it does not solve

The abstract does not specify how to selectively access, manipulate, or subclass these neurons experimentally.

Source 1DOIPubMed

Alternatives

The abstract contrasts VTA GABA neurons with the more commonly emphasized VTA dopaminergic system.

Source 1DOIPubMed

Evidence Snippets

However, the VTA is not only made of dopamine (DA) cells, as approximately 30% of cells in the VTA are GABA neurons. These neurons play a dual role, as VTA GABA neurons provide both local inhibition of VTA DA neurons and long-range inhibition of several distal brain regions.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1behavioral role summarysupports2019Source 1DOIPubMed

VTA GABA neurons are recognized as mediators of reward and aversion in their own right.

Claim 2composition summarysupports2019Source 1DOIPubMed

Approximately 30% of cells in the ventral tegmental area are GABA neurons.

Claim 3functional role summarysupports2019Source 1DOIPubMed

VTA GABA neurons provide both local inhibition of VTA dopamine neurons and long-range inhibition of distal brain regions.

Claim 4translational relevance summarysupports2019Source 1DOIPubMed

VTA GABA neurons are potential targets for treatment of addiction, depression, and other stress-linked disorders.